Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NH104 tablets in adults with insomnia disorder: randomized double-blind placebo-controlled phase Ib/II study
CTR20262037Phase 2Active
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NH104 in Insomnia, sponsored by Jiangsu Nhwa Pharmaceutical. Started May 2026; status: active.
02
Drugs
NH104
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20262037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262037.